Vaccine Damage Payments Act — [Mr Martin Caton in the Chair]

Part of the debate – in Westminster Hall at 3:23 pm on 24 March 2015.

Alert me about debates like this

Photo of Richard Benyon Richard Benyon Conservative, Newbury 3:23, 24 March 2015

I apologise for not being here for the start of the debate; I meant no disrespect to Mr Brown, who has been a tireless campaigner on the issue. I will take only a brief amount of the House’s time, partly because I must again be rude and leave the debate before the end—it is that stage of the parliamentary process.

I want to express my gratitude and that of my constituent. The hon. Gentleman spent two hours going in great detail through the difficulties suffered by her daughter, a 24-year-old girl who has suffered from the HPV vaccine Cervarix. The anti-NMDA receptor antibody effect on her is massive. My constituent’s daughter will require financial support for life—disability benefits and a range of other support to get her through her difficulties. Those difficulties result from a reaction to a vaccine that has been an enormous success in this country in protecting young women from a viral condition, but which, in certain circumstances, has the effect I have mentioned. There is more evidence not just in this country but abroad, and there is emerging research.

I hope that the Minister will recognise the circumstances, and recognise also that more needs to be done, including looking at research from abroad. We should understand the difficulties of the individual concerned, who must go to endless meetings that require explanation of a complex medical condition not understood by people in the benefits world—and why should it be? It requires someone with a detailed understanding of a narrow field of clinical work to understand it. It is a question of constantly having to explain it again to someone new, and recognising that the situation will last a lifetime.

Perhaps a miracle cure or a way to reverse the condition will be found, but we cannot say. At the moment we need the Government to recognise—through the benefits delivery networks, as well as in terms of the Minister’s responsibilities—that there are people who acted for the right reasons and who need support. They need support in their battle to get their condition recognised and understood. There is a growing experience across developed economies, where the right measures are taken to protect young people from disease, of people being affected in the wrong way in certain circumstances. I hope that in future the system will permit greater protection for people such as my constituents. I applaud the hon. Member for Dumfries and Galloway for calling the debate.